Exchange: AMEX Industry: Medical Devices
-1.15% $17.21
America/New_York / 10 mai 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 148.97 mill |
EPS: | 0.450 |
P/E: | 38.24 |
Earnings Date: | May 07, 2024 |
SharesOutstanding: | 8.66 mill |
Avg Daily Volume: | 0.0391 mill |
RATING 2024-05-10 |
---|
A |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Buy | |
Return On Asset: | Strong Buy | |
DE: | Sell | |
P/E: | Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
3.11x |
Company: PE 38.24 | sector: PE 12.30 |
PE RATIO: COMPANY / INDUSTRY |
---|
1.81x |
Company: PE 38.24 | industry: PE 21.09 |
DISCOUNTED CASH FLOW VALUE |
---|
$10.46 (-39.20%) $-6.75 |
Date: 2024-05-12 |
Expected Trading Range (DAY) |
---|
$ 16.41 - 18.01 ( +/- 4.67%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Cunniff James L. | Buy | 9 000 | Common Stock |
2023-12-14 | Summers Andrew | Buy | 28 797 | Common Stock |
2023-12-01 | Erickson Stan K. | Buy | 3 000 | Common Stock |
2023-12-01 | Fluet Gregory | Buy | 3 000 | Common Stock |
2023-12-01 | Skarvan Kathleen | Buy | 3 000 | Common Stock |
INSIDER POWER |
---|
60.84 |
Last 87 transactions |
Buy: 857 753 | Sell: 271 483 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $17.21 (-1.15% ) |
Volume | 0.0199 mill |
Avg. Vol. | 0.0391 mill |
% of Avg. Vol | 50.85 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.